Correlation Between Pharvaris and Acrivon Therapeutics,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pharvaris and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pharvaris and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pharvaris BV and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Pharvaris and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pharvaris with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pharvaris and Acrivon Therapeutics,.

Diversification Opportunities for Pharvaris and Acrivon Therapeutics,

PharvarisAcrivonDiversified AwayPharvarisAcrivonDiversified Away100%
0.66
  Correlation Coefficient

Poor diversification

The 3 months correlation between Pharvaris and Acrivon is 0.66. Overlapping area represents the amount of risk that can be diversified away by holding Pharvaris BV and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Pharvaris is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pharvaris BV are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Pharvaris i.e., Pharvaris and Acrivon Therapeutics, go up and down completely randomly.

Pair Corralation between Pharvaris and Acrivon Therapeutics,

Given the investment horizon of 90 days Pharvaris BV is expected to under-perform the Acrivon Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Pharvaris BV is 3.91 times less risky than Acrivon Therapeutics,. The stock trades about -0.32 of its potential returns per unit of risk. The Acrivon Therapeutics, Common is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest  555.00  in Acrivon Therapeutics, Common on November 30, 2024 and sell it today you would lose (21.00) from holding Acrivon Therapeutics, Common or give up 3.78% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Pharvaris BV  vs.  Acrivon Therapeutics, Common

 Performance 
JavaScript chart by amCharts 3.21.15Dec2025Feb -20-10010
JavaScript chart by amCharts 3.21.15PHVS ACRV
       Timeline  
Pharvaris BV 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Pharvaris BV has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb1618202224
Acrivon Therapeutics, 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in March 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
JavaScript chart by amCharts 3.21.15DecJanFebJanFeb55.566.577.58

Pharvaris and Acrivon Therapeutics, Volatility Contrast

   Predicted Return Density   
JavaScript chart by amCharts 3.21.15-5.79-4.37-2.94-1.52-0.09661.22.483.765.046.33 0.0100.0150.0200.0250.0300.035
JavaScript chart by amCharts 3.21.15PHVS ACRV
       Returns  

Pair Trading with Pharvaris and Acrivon Therapeutics,

The main advantage of trading using opposite Pharvaris and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pharvaris position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.
The idea behind Pharvaris BV and Acrivon Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Transaction History
View history of all your transactions and understand their impact on performance
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum